Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;148(2):245-55.
doi: 10.1111/j.1365-2141.2009.07943.x. Epub 2009 Oct 12.

Genome wide DNA-profiling of HIV-related B-cell lymphomas

Affiliations

Genome wide DNA-profiling of HIV-related B-cell lymphomas

Daniela Capello et al. Br J Haematol. 2010 Jan.

Abstract

Non-Hodgkin lymphomas (NHL) represent a frequent complication of human immunodeficiency virus (HIV) infection. To elucidate HIV-NHL pathogenesis, we performed a genome-wide DNA profiling based on a single nucleotide polymorphism-based microarray comparative genomic hybridization in 57 HIV-lymphomas and, for comparison, in 105 immunocompetent diffuse large B-cell lymphomas (IC-DLBCL). Genomic complexity varied across HIV-NHL subtypes. HIV-Burkitt lymphoma showed a significantly lower number of lesions than HIV-DLBCL (P = 0.032), whereas the median number of copy number changes was significantly higher in Epstein-Barr virus negative (EBV-) HIV-DLBCL (42.5, range 8-153) compared to EBV+ cases (22; range 3-41; P = 0.029). Compared to IC-DLBCL, HIV-DLBCL displayed a distinct genomic profile with no gains of 18q and specific genetic lesions. Fragile sites-associated genes, including FHIT (FRA3B), WWOX (FRA16D), DCC (FRA18B) and PARK2 (FRA6E) were frequently inactivated in HIV-NHL by interstitial deletions, and a significantly higher prevalence of FHIT alterations was observed in HIV-DLBCL compared to IC-DLBCL. The same genes involved by fragile site deletions were also frequently affected by aberrant methylation of regulative regions.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Frequency of DNA gains (up) and losses (down) observed in 11 HIV-BL (A), 25 HIV-DLBCL (B), 105 IC-DLBCL (C), four HIV-PCNSL (D) and eight HIV-PEL (E). X-axis, chromosome localization and physical mapping; Y-axis, percentage of cases showing the aberrations.
Fig 2
Fig 2
Expression analysis of FHIT and WWOX mRNA by real-time quantitative RT-PCR. Levels of FHIT (A) and WWOX (B) mRNA in HIV-NHL samples with and without genetic and/or epigenetic alterations of the gene were normalized to the endogenous reference GUSB mRNA to obtain the normalized threshold cycle (ΔCt) for each sample. The median ΔCt value was set to 1. The ΔCt value of FHIT (A) and WWOX (B) of cases without alterations of the gene was related to the ΔCt value of FHIT (A) and WWOX (B) of cases displaying genetic and/or epigenetic alterations to obtain the relative threshold cycle (ΔΔCt). The (2−ΔΔCt) algorithm was used to determine the relative expression of FHIT and WWOX mRNA. Statistical analysis, performed by the non parametric Mann-Whitney test with Bonferroni adjustment, revealed a significant difference in FHIT and WWOX expression between samples without genetic and/or epigenetic alterations and HIV-NHL cases displaying alterations of the gene (p=0.01 for FHIT, and p<0.001 for WWOX).

References

    1. Agirre X, Roman-Gomez J, Vazquez I, Jimenez-Velasco A, Garate L, Montiel-Duarte C, Artieda P, Cordeu L, Lahortiga I, Calasanz MJ, Heiniger A, Torres A, Minna JD, Prosper F. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. Int J Cancer. 2006;118:1945–1953. - PubMed
    1. Aqeilan RI, Croce CM. WWOX in biological control and tumorigenesis. J Cell Physiol. 2007;212:307–310. - PubMed
    1. Aqeilan RI, Trapasso F, Hussain S, Costinean S, Marshall D, Pekarsky Y, Hagan JP, Zanesi N, Kaou M, Stein GS, Lian JB, Croce CM. Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci U S A. 2007;104:3949–3954. - PMC - PubMed
    1. Arakawa H. Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer. 2004;4:978–987. - PubMed
    1. Bacolod MD, Schemmann GS, Wang S, Shattock R, Giardina SF, Zeng Z, Shia J, Stengel RF, Gerry N, Hoh J, Kirchhoff T, Gold B, Christman MF, Offit K, Gerald WL, Notterman DA, Ott J, Paty PB, Barany F. The signatures of autozygosity among patients with colorectal cancer. Cancer Res. 2008;68:2610–2621. - PMC - PubMed

Publication types